Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369259
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-04-12
Brief Title:
Open-label Phase 2 Study of Avutometinib RAFMEK Clamp in Combination With Defactinib FAK Inhibitor and Cetuximab in Patients With Unresectable Anti-EGFR-Refractory Advanced Colorectal Cancer
Sponsor:
Organization:
MD Anderson Cancer Center